This publication is classified as a narrative review focusing on agricultural biotechnology rather than human clinical trials. The scope encompasses legume crops, specifically listing soybean, cowpea, chickpea, groundnut, pea, barrel clover, alfalfa, and Lotus japonicus. The review evaluates various gene editing technologies, including CRISPR/Cas9, TALENs, ZFNs, base editing, and prime editing, alongside associated gRNA design tools.
Regarding specific findings, the authors synthesize data indicating that CRISPR/Cas9 is the most widely adopted technology within these legume species. Additionally, the CRISPR-P gRNA design tool is identified as the most used tool for design purposes. These conclusions are qualitative observations drawn from the reviewed literature rather than quantitative meta-analytic results. No effect sizes, absolute numbers, or statistical significance values are reported in the source material.
Significant data gaps exist regarding the depth of safety and outcome information. The source explicitly states that adverse events, serious adverse events, discontinuations, and tolerability are not reported. Furthermore, sample size, setting, follow-up duration, and practice relevance are not reported. The absence of these details prevents assessment of risk or efficacy in a clinical context.
For healthcare professionals, the practice relevance is not reported. The review does not provide evidence regarding human health outcomes or safety profiles relevant to clinical practice. Clinicians should recognize this source as an overview of agricultural gene editing applications without direct implications for patient care or therapeutic decision-making.
View Original Abstract ↓
Legumes are among the most important protein-rich crops in global agri-food systems. To meet the rising protein demand of a growing population, significant efforts are underway to enhance legume yield, nutritional quality, and resilience to environmental stresses through the manipulation of key genetic traits. Advanced technologies-including genetic engineering, gene editing, genomic selection, next-generation sequencing, single-cell genomics, and multi-omics-are accelerating legume improvement due to their high precision and efficiency. This review focuses on major gene-editing technologies, namely, CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9), TALENs (Transcription Activator-Like Effector Nucleases), ZFNs (Zinc Finger Nucleases), base editing (BE), and prime editing (PE), and their applications in key legume crops such as soybean (Glycine max), cowpea (Vigna unguiculata), chickpea (Cicer arietinum), groundnut (Arachis hypogaea), pea (Pisum sativum), barrel clover (Medicago truncatula), alfalfa (Medicago sativa), and Lotus japonicus. Among these platforms, CRISPR/Cas9 is the most widely adopted in legumes, largely due to its simplicity, versatility, and dependence on accurate genome sequence information and guide RNA (gRNA) design. Advances in next-generation sequencing and the growing availability of intuitive online gRNA design tools have streamlined CRISPR workflows, improving accessibility and precision. The present review indicates that CRISPR-P is the most used gRNA design tool in legume research, likely due to its early development for plant systems and integrated off-target prediction features. Therefore, alongside reviewing gene-editing applications, we emphasized the critical role of robust gRNA design tools as a foundation for successful genome editing. Future integration of artificial intelligence and large language models is expected to further enhance target prediction accuracy, minimize off-target effects, and enable more precise genome-editing strategies in legumes.